Source: Pharmaceutical Benefits Scheme (AU) Revision Year: 2023 Publisher: Arrotex Pharmaceuticals Pty Ltd, 15 – 17 Chapel Street, Cremorne, Victoria 3121
Telmisartan.
| Pharmaceutical Form |
|---|
|
TELTARTAN is available as tablets for oral administration. TELTARTAN tablets are white to off-white, biconvex, oval-shaped, uncoated tablets. TELTARTAN 40 mg tablets have one face marked with L203 and plain on the other side. TELTARTAN 80 mg tablets have one face marked with L204 and plain on the other side. |
TELTARTAN contains the active ingredient telmisartan. Tablets containing 40 mg and 80 mg of telmisartan are available.
For the full list of excipients, see Section 6.1 LIST OF EXCIPIENTS.
| Active Ingredient | Description | |
|---|---|---|
| Telmisartan |
Telmisartan is an orally active and specific angiotensin II receptor (type AT1) antagonist. Telmisartan selectively binds the AT1 receptor. The binding is long-lasting. |
| List of Excipients |
|---|
|
The excipients are povidone, meglumine, sodium hydroxide, mannitol, sodium stearylfumarate and magnesium stearate. |
TELTARTAN tablets are available in blister packs containing 28 tablets.
Arrotex Pharmaceuticals Pty Ltd, 15 – 17 Chapel Street, Cremorne, Victoria 3121
Date of first approval: 19 May 2014
| Drug | Countries | |
|---|---|---|
| TELTARTAN | Australia, Nigeria |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
